| Accession Number: | 0000950103-21-003634 |
| Date: | 2021-03-03 |
| Issuer: | ROYALTY PHARMA PLC (RPRX) |
| Original Submission Date: |
COYNE TERRANCE P.
C/O ROYALTY PHARMA PLC
110 EAST 59TH STREET
NEW YORK, NY 10022
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| CLASS A ORDINARY SHARES | 2021-03-03 | S | 29,820 | d | $43.71 | 270,180 | indirect | ||
| CLASS A ORDINARY SHARES | 2021-03-03 | S | 57,723 | d | $45.09 | 212,457 | indirect | ||
| CLASS A ORDINARY SHARES | 2021-03-03 | S | 11,001 | d | $45.86 | 201,456 | indirect | ||
| CLASS A ORDINARY SHARES | 2021-03-03 | S | 1,456 | d | $46.83 | 200,000 | indirect | ||
| CLASS A ORDINARY SHARES | 0 | $0.00 | 1,500 | direct | |||||
| CLASS A ORDINARY SHARES | 0 | $0.00 | 1,450 | indirect | |||||
| CLASS A ORDINARY SHARES | 0 | $0.00 | 23,270 | indirect | |||||
| CLASS A ORDINARY SHARES | 0 | $0.00 | 24,170 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the reported price in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $43.47 to $44.46 per share. the holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| f2 | the reported price in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $44.50 to $45.46 per share. the holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| f3 | the reported price in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $45.57 to $46.41 per share. the holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
